Is ELIXF or MRK a better dividend investment in 2026?

ELIXF currently yields 5970.15% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: ELIXF offers higher current income.

What is the dividend yield difference between ELIXF and MRK?

ELIXF has a forward dividend yield of 5970.15% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 5967.39 percentage points.

Home › Compare › ELIXF vs MRK

ELIXF vs MRK: Dividend Comparison 2026

ELIXF yields 5970.15% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ELIXF wins by $349757300762301.94M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ELIXF

● Live price

5970.15%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$349757300762302.00M

Annual income

$338,600,487,421,434,700,000.00

Full ELIXF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — ELIXF vs MRK

📍 ELIXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ELIXF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ELIXF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ELIXF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELIXF

Annual income on $10K today (after 15% tax)

$507,462.69/yr

After 10yr DRIP, annual income (after tax)

$287,810,414,308,219,520,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, ELIXF beats the other by $287,810,414,308,219,520,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELIXF + MRK for your $10,000?

ELIXF: 50%MRK: 50%

100% MRK50/50100% ELIXF

Portfolio after 10yr

$174878650381151.03M

Annual income

$169,300,243,710,717,360,000.00/yr

Blended yield

96.81%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ELIXF

No analyst data

Altman Z

-68.9

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELIXF buys

MRK buys

No recent congressional trades found for ELIXF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricELIXFMRK

Forward yield	5970.15% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$349757300762302.00M ✓	$56.8K
Annual income after 10y	$338,600,487,421,434,700,000.00 ✓	$9,798.13
Total dividends collected	$349006491373237.88M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ELIXF vs MRK ($10,000, DRIP)

Year	ELIXF Portfolio	ELIXF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$607,715	$597,014.93	$11,206	$366.19	+$596.5K → ELIXF
2	$34,558,188	$33,907,932.79	$12,650	$502.35	+$34.55M → ELIXF
3	$1,839,034,548	$1,802,057,287.52	$14,407	$694.19	+$1839.02M → ELIXF
4	$91,591,647,409	$89,623,880,441.98	$16,585	$967.82	+$91591.63M → ELIXF
5	$4,269,634,661,039	$4,171,631,598,311.20	$19,342	$1,363.89	+$4269634.64M → ELIXF
6	$186,311,225,789,697	$181,742,716,702,385.70	$22,913	$1,947.19	+$186311225.77M → ELIXF
7	$7,611,116,385,606,142	$7,411,763,374,011,165.00	$27,662	$2,823.89	+$7611116385.58M → ELIXF
8	$291,118,268,537,960,000	$282,974,374,005,361,470.00	$34,159	$4,173.35	+$291118268537.93M → ELIXF
9	$10,426,928,355,950,688,000	$10,115,431,808,615,070,000.00	$43,337	$6,308.80	+$10426928355950.64M → ELIXF
10	$349,757,300,762,302,000,000	$338,600,487,421,434,700,000.00	$56,776	$9,798.13	+$349757300762301.94M → ELIXF

ELIXF vs MRK: Complete Analysis 2026

ELIXF — Stock

Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis-related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.

Full ELIXF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this ELIXF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELIXF vs SCHD ELIXF vs JEPI ELIXF vs O ELIXF vs KO ELIXF vs MAIN ELIXF vs JNJ ELIXF vs ABBV ELIXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.